Image

India Launches First Indigenous H5N1 Bird Flu Vaccine for Chickens

India Launches First Indigenous H5N1 Bird Flu Vaccine for Chickens

Overview

India has launched its first indigenous H5N1 bird flu vaccine for chickens. Learn about its development, price, target virus, economic impact and importance for poultry farmers.

 

H5N1 Vaccine 2026

India has developed its first indigenous H5N1 bird flu vaccine for chickens. Union Agriculture Minister Shivraj Singh Chouhan dedicated it to the nation on 20 November 2026 in Bhopal, Madhya Pradesh. ICAR-NIHSAD developed the vaccine. It costs just ₹1–2 per dose.

Source: PIB – Indigenous H5N1 Bird Flu Vaccine

India's First Indigenous H5N1 Vaccine

The ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal, developed this vaccine. It targets the H5N1 virus of Clade 2.3.2.1a. The vaccine will help protect chickens against highly pathogenic avian influenza.

The government described it as the first vaccine developed for this particular H5N1 variant. It also stated that no specific commercial vaccine for this clade was available earlier.

Key Details

Particular Details
Vaccine Indigenous H5N1 vaccine
Disease Highly Pathogenic Avian Influenza
Virus subtype H5N1
Target clade 2.3.2.1a
Vaccine type Inactivated
Target animal Chickens
Developed by ICAR-NIHSAD
Location Bhopal, Madhya Pradesh
Dedicated on 20 November 2026
Union Minister Shivraj Singh Chouhan
Price ₹1–2 per dose

Source: PIB – Ministry of Agriculture and Farmers Welfare

What Is an Inactivated Vaccine?

An inactivated vaccine uses a virus that cannot reproduce. It cannot cause the disease through viral replication. Instead, it helps the body's immune system recognise the virus and develop protection.

The new H5N1 vaccine uses this approach. It targets the virus strain found in Indian poultry outbreaks.

What Is Bird Flu?

Bird flu is also called avian influenza. It is caused by influenza A viruses. Some strains can cause severe disease in poultry.

Highly Pathogenic Avian Influenza (HPAI) can cause very high mortality among infected birds. Outbreaks can force authorities to cull infected and exposed birds. They can also lead to trade restrictions and heavy losses for poultry farmers.

Source: World Organisation for Animal Health (WOAH) – Avian Influenza

Why Does Clade 2.3.2.1a Matter?

Scientists group related virus strains into genetic groups called clades. These groups help them study how viruses change and spread.

According to the Ministry of Agriculture, Clade 2.3.2.1a has caused most bird flu outbreaks in Indian chickens. The same strain has also appeared in other animals, including mammals. The government release also reported three human cases linked to this strain.

A vaccine against this clade can strengthen India's efforts to control bird flu.

Source: PIB – H5N1 Vaccine Development

Economic Impact of Bird Flu in India

Bird flu can affect farmers, poultry businesses and the wider economy. Farmers may lose birds and face restrictions on selling poultry products. These problems can also affect supply chains and market prices.

The Ministry of Agriculture shared the following figures:

Indicator Government-reported figure
First reported outbreak in India 2006
Combined H5N1 and H5N8 outbreaks since 2006 Over 500
Estimated losses in the 2006 outbreak ₹2,200–3,000 crore
Possible GDP growth impact of a major outbreak Up to 1.5%
Poultry population potentially at risk Over 20%
Losses linked to an outbreak in Manipur 0.5% of State GDP

These figures show why early detection, biosecurity and vaccination matter.

Source: PIB – Government Background on H5N1

Public Health Importance

H5N1 is a zoonotic virus. This means it can spread from animals to humans. Human infections are uncommon, but they can cause serious illness.

The government release cited WHO data of 1,003 reported human H5N1 cases and 479 deaths across 25 countries since 2003. These are figures quoted in the release.

Controlling bird flu in poultry can reduce exposure to infected birds and lower the risk of animal-to-human transmission.

Source: WHO – Avian Influenza

About ICAR-NIHSAD

ICAR-NIHSAD is based in Bhopal, Madhya Pradesh. It works under the Indian Council of Agricultural Research (ICAR). The institute studies serious animal diseases and supports their diagnosis, monitoring and control.

It has also developed indigenous vaccines for diseases such as Gumboro, Classical Swine Fever and African Swine Fever.

Source: ICAR-NIHSAD Official Website

New ₹300-Crore Animal Disease Laboratory

During the vaccine dedication programme, Shivraj Singh Chouhan announced a new animal disease research laboratory in Bhopal. The proposed facility will cost around ₹300 crore.

It is expected to strengthen India's research capacity in animal health and disease control.

Source: PIB – 20 November 2026 Announcement

Exam-Focused Points :

  • India dedicated its first indigenous H5N1 chicken vaccine on 20 November 2026.

  • ICAR-NIHSAD, Bhopal, developed the vaccine.

  • It targets H5N1 Clade 2.3.2.1a.

  • The vaccine is inactivated and costs ₹1–2 per dose.

  • India first reported bird flu in 2006.

  • More than 500 combined H5N1 and H5N8 outbreaks have occurred since 2006, according to the government release.

  • The Union Government announced a ₹300-crore animal disease research laboratory in Bhopal.

FAQs :

Q1. Who developed India's indigenous H5N1 vaccine?

Ans: ICAR-NIHSAD, Bhopal.

Q2. Which virus does the vaccine target?

Ans: H5N1 Clade 2.3.2.1a.

Q3. What is the price of the vaccine?

Ans: ₹1–2 per dose.

Q4. When was the vaccine dedicated to the nation?

Ans: 20 November 2026.

Q5. Where is ICAR-NIHSAD located?

Ans: Bhopal, Madhya Pradesh.

Month: 

Category: 

1